Search research articles
Contact Us
Filters
Showing results (41-50 of 558) with videos related to
Page
of 56
Sort By:
SSM - Population Health
|
October 16, 2023
The average life expectancy of persons with disabilities in China
Peng Zhan, Dongwen Li, Xiang Zhang, et al.
Mini Reviews in Medicinal Chemistry
|
July 16, 2009
Sulfanyltriazole/tetrazoles: a promising class of HIV-1 NNRTIs
Peng Zhan, Zhenyu Li, Xinyong Liu, et al.
Journal of Medicinal Chemistry
|
October 29, 2015
Anti-HIV Drug Discovery and Development: Current Innovations and Future Trends
Peng Zhan, Christophe Pannecouque, Erik De Clercq, et al.
Chemical Communications (Cambridge, England)
|
May 28, 2021
<i>In situ</i> creation of multi-metallic species inside porous silicate materials with tunable catalytic properties
Yang-Yang Liu, Guo-Peng Zhan, Chuan-De Wu
Mini Reviews in Medicinal Chemistry
|
October 16, 2008
Recent advances in the research of HIV-1 RNase H inhibitors
Fang Yu, Xinyong Liu, Peng Zhan, et al.
Current Pharmaceutical Design
|
January 13, 2012
Recent progress in small molecule CCR5 antagonists as potential HIV-1 entry inhibitors
Wenwen Chen, Peng Zhan, Erik De Clercq, et al.
Drug Discovery Today
|
November 3, 2025
Therapeutic approaches to addressing drug resistance by targeting membranes and associated structures
Shaoqing Du, Luis Menéndez-Arias, Xueping Hu, et al.
Oncology Reports
|
July 7, 2022
HIF‑1α and MBP1 are associated with the progression of breast cancer cells by repressing β‑catenin transcription
Ying Zhuang, Xiang Li, Peng Zhan, et al.
Expert Opinion on Therapeutic Patents
|
November 13, 2015
Novel diarylpyrimidines and diaryltriazines as potent HIV-1 NNRTIs with dramatically improved solubility: a patent evaluation of US20140378443A1
Boshi Huang, Dongwei Kang, Jiapei Yang, et al.
Epigenomics
|
December 10, 2015
Medicinal chemistry insights in the discovery of novel LSD1 inhibitors
Xueshun Wang, Boshi Huang, Takayoshi Suzuki, et al.
Page
of 56
Search research articles
Search
Showing results (41-50 of 558) with videos related to
Sort By:
Page
of 56
SSM - Population Health
|
October 16, 2023
The average life expectancy of persons with disabilities in China
Peng Zhan, Dongwen Li, Xiang Zhang, et al.
Mini Reviews in Medicinal Chemistry
|
July 16, 2009
Sulfanyltriazole/tetrazoles: a promising class of HIV-1 NNRTIs
Peng Zhan, Zhenyu Li, Xinyong Liu, et al.
Journal of Medicinal Chemistry
|
October 29, 2015
Anti-HIV Drug Discovery and Development: Current Innovations and Future Trends
Peng Zhan, Christophe Pannecouque, Erik De Clercq, et al.
Chemical Communications (Cambridge, England)
|
May 28, 2021
<i>In situ</i> creation of multi-metallic species inside porous silicate materials with tunable catalytic properties
Yang-Yang Liu, Guo-Peng Zhan, Chuan-De Wu
Mini Reviews in Medicinal Chemistry
|
October 16, 2008
Recent advances in the research of HIV-1 RNase H inhibitors
Fang Yu, Xinyong Liu, Peng Zhan, et al.
Current Pharmaceutical Design
|
January 13, 2012
Recent progress in small molecule CCR5 antagonists as potential HIV-1 entry inhibitors
Wenwen Chen, Peng Zhan, Erik De Clercq, et al.
Drug Discovery Today
|
November 3, 2025
Therapeutic approaches to addressing drug resistance by targeting membranes and associated structures
Shaoqing Du, Luis Menéndez-Arias, Xueping Hu, et al.
Oncology Reports
|
July 7, 2022
HIF‑1α and MBP1 are associated with the progression of breast cancer cells by repressing β‑catenin transcription
Ying Zhuang, Xiang Li, Peng Zhan, et al.
Expert Opinion on Therapeutic Patents
|
November 13, 2015
Novel diarylpyrimidines and diaryltriazines as potent HIV-1 NNRTIs with dramatically improved solubility: a patent evaluation of US20140378443A1
Boshi Huang, Dongwei Kang, Jiapei Yang, et al.
Epigenomics
|
December 10, 2015
Medicinal chemistry insights in the discovery of novel LSD1 inhibitors
Xueshun Wang, Boshi Huang, Takayoshi Suzuki, et al.
Page
of 56